null

Ladiratuzumab Biosimilar (Anti-LIV-1) Antibody (HDBS0112)

SKU:
HDBS0112
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
LIV-1
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€399
Frequently bought together:

Description

system_update_altDatasheet

Ladiratuzumab (Anti-LIV-1) Biosimilar Antibody (HDBS0112)

The Ladiratuzumab Biosimilar Anti-LIV-1 Antibody is a cutting-edge research tool for studying the LIV-1 protein, a key player in breast cancer progression and metastasis. This monoclonal antibody, engineered for high specificity and sensitivity, is ideal for use in various immunoassays and immunohistochemistry applications.LIV-1, a transmembrane protein overexpressed in breast cancer cells, is associated with tumor growth, invasion, and resistance to chemotherapy. Targeting LIV-1 with antibodies like ladiratuzumab has shown promise in inhibiting tumor progression and improving treatment outcomes in preclinical studies.

Researchers in the fields of oncology, molecular biology, and immuno-oncology will benefit from the exceptional performance of this biosimilar antibody in their investigations of LIV-1's role in breast cancer development and potential therapeutic interventions. Stay ahead in cancer research with the ladiratuzumab biosimilar anti-LIV-1 antibody from Assay Genie.